![](/img/cover-not-exists.png)
Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group
Gjerset, GF, Pike, MC, Mosley, JW, Hassett, J, Fletcher, MA, Donegan, E, Parker, JW, Counts, RB, Zhou, Y, Kasper, CKVolume:
84
Journal:
Blood
DOI:
10.1182/blood.v84.5.1666.1666
Date:
September, 1994
File:
PDF, 615 KB
1994